PURPOSE OF REVIEW: Traumatic optic neuropathy is common clinical problem for neuro-ophthalmologists, without evidence-based guidelines regarding evaluation and therapy. Although no large natural history or randomized controlled trial has been published, corticosteroid therapy, surgical decompression or observation remains the mainstays of therapy. RECENT FINDINGS: Additional research is ongoing, concerning medications and therapies to enhance visual recovery following trauma; future treatments may concern neuroprotective factors and retinal ganglion cell regeneration. SUMMARY: A randomized control trial would likely provide the best understanding of the disease as well as reliable treatment guide.
PURPOSE OF REVIEW: Traumatic optic neuropathy is common clinical problem for neuro-ophthalmologists, without evidence-based guidelines regarding evaluation and therapy. Although no large natural history or randomized controlled trial has been published, corticosteroid therapy, surgical decompression or observation remains the mainstays of therapy. RECENT FINDINGS: Additional research is ongoing, concerning medications and therapies to enhance visual recovery following trauma; future treatments may concern neuroprotective factors and retinal ganglion cell regeneration. SUMMARY: A randomized control trial would likely provide the best understanding of the disease as well as reliable treatment guide.
Authors: Ramachandra P Reddy; Uttam K Bodanapally; Kathirkamanathan Shanmuganathan; Giulia Van der Byl; David Dreizin; Lee Katzman; Robert Kang Shin Journal: Emerg Radiol Date: 2015-01-07
Authors: Aria Ghahramani; Mona L Camacci; Rucha Borkhetaria; Anne Poulsen; Samuel Beckstead; Christopher Weller Journal: Case Rep Ophthalmol Date: 2021-06-18